Immucor, Inc. BLUD is spiking, up some 3% on reports that Dealreporter is reporting private equity interest in the company.
According to the source, at least two financial sponsors may be circling Immucor.
Immucor, Inc. engages in the development, manufacture, and sale of reagents and automated systems.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in